| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive Chairman
3 companies
Doyle William F is an Executive Chairman at NovoCure Ltd with holdings across 3 companies. Recent SEC Form 4 filings include 6 buys and 6 sells.
Estimated insider holdings value: $12.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 9, 2019 | NVCR Novocure Ltd | Executive Chairman | Sell | 31,460 | $47.37 | $1,490,386.04 | -3.4% | |
| May 8, 2019 | NVCR Novocure Ltd | Executive Chairman | Sale+OE | 64,316 | $47.60 | $3,061,143.24 | -3.6% | |
| May 6, 2019 | NVCR Novocure Ltd | Executive Chairman | Sale+OE | 29,038 | $48.07 | $1,395,914.74 | -3.4% | |
| May 3, 2019 | NVCR Novocure Ltd | Executive Chairman | Sale+OE | 29,966 | $45.21 | $1,354,643.00 | -3.7% | |
| Feb 28, 2019 | NVCR Novocure Ltd | Executive Chairman | Sale+OE | 3,097 | $53.68 | $166,246.96 | -0.3% | |
| Dec 20, 2018 | NERV Minerva Neurosciences, Inc. | Director | Buy | 2,000 | $6.50 | $13,000.00 | +9.7% | |
| Dec 11, 2018 | NERV Minerva Neurosciences, Inc. | Director | Buy | 6,000 | $7.97 | $47,800.00 | +19.2% | |
| Nov 20, 2018 | NERV Minerva Neurosciences, Inc. | Director | Buy | 2,000 | $8.20 | $16,400.00 | +15.9% | |
| Oct 11, 2018 | NERV Minerva Neurosciences, Inc. | Director | Buy | 600 | $10.00 | $6,000.00 | +5.0% | |
| Sep 17, 2018 | NERV Minerva Neurosciences, Inc. | Director | Buy | 1,800 | $10.50 | $18,900.00 | +17.6% |